- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Sofiva Genomics Co Ltd (6615)
Sofiva Genomics Co Ltd stock price live, this page displays TWO 6615 stock exchange data. View the 6615 premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Sofiva Genomics Co Ltd real time stock price chart below.
What Is the Sofiva Genomics Co Ltd Stock Price Today?
The Sofiva Genomics Co Ltd stock price today is 32.95.
What Is the Stock Symbol for Sofiva Genomics Co Ltd?
The stock symbol for Sofiva Genomics Co Ltd is ""6615.""
What Stock Exchange Does Sofiva Genomics Co Ltd Trade On?
Sofiva Genomics Co Ltd is listed and trades on the TPEX stock exchange.
Is Sofiva Genomics Co Ltd a Good Stock to Buy?
Determining whether Sofiva Genomics Co Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 6615 quote. (ISIN: TW0006615008)
What Is the Sofiva Genomics Co Ltd Stock Price Today?
The Sofiva Genomics Co Ltd stock price today is 32.95.
What Is the Stock Symbol for Sofiva Genomics Co Ltd?
The stock symbol for Sofiva Genomics Co Ltd is ""6615.""
What Stock Exchange Does Sofiva Genomics Co Ltd Trade On?
Sofiva Genomics Co Ltd is listed and trades on the TPEX stock exchange.
Is Sofiva Genomics Co Ltd a Good Stock to Buy?
Determining whether Sofiva Genomics Co Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 6615 quote. (ISIN: TW0006615008)
TPEX
Currency in TWD
32.95
+1.85(+5.95%)
Closed·
Fair Value
An estimate of a Sofiva Genomics's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
30.80
32.95
52 wk Range
29.00
58.60
6615 Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
6615 is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a Sofiva Genomics's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
30.8032.95
52 wk Range
29.0058.60
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(0.91%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(0.91%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
6615 Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Sofiva Genomics's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Significant return over the last week
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Buy
Sofiva Genomics Co Ltd Company Profile
Sofiva Genomics Co.,Ltd. provides genetic testing services in Taiwan and internationally. The company offers prenatal services, including thalassemia carrier screening; tests for microdeletion syndromes and single-gene abnormalities; detection of common chromosome abnormalities, selected microdeletions syndromes, and selected skeletal dysplasia genetic mutations; multiple genetic diseases detection; folate metabolism genetic screening; spinal muscular atrophy carrier screening; fragile X syndrome carrier screening; congenital infection screening; risk assessment for early/late-onset preeclampsia; maternal serum screening for down syndrome; and karyotyping. It also provides cancer services, such as cancer scans; real-time monitoring of tumor dynamics; hereditary cancer related genetic tests; and hereditary women's cancer tests for breast, colon, ovarian, and endometrial cancer, as well as human papillomavirus screening. In addition, the company offers rare diseases genetic testing services; and preimplantation genetic diagnosis and NGS-based preimplantation genetic screening services. Further, it provides new-born genetic testing services comprising baby scans; hereditary sensorineural hearing loss screening; congenital central hypoventilation syndrome screening; congenital cytomegalovirus infection screening test; and atopic dermatitis genetic screening. Additionally, the company offers biochemical and chromosome testing, as well as advisory and support services. It serves expectant parents, patients with genetic disorders, and their families. Sofiva Genomics Co.,Ltd. was founded in 2012 and is based in Taipei, Taiwan.
Compare 6615 to Peers and Sector
Metrics to compare | 6615 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship6615PeersSector | |
|---|---|---|---|---|
P/E Ratio | 249.1x | 21.1x | −0.5x | |
PEG Ratio | −2.88 | 0.06 | 0.00 | |
Price/Book | 1.1x | 1.2x | 2.6x | |
Price / LTM Sales | 1.6x | 3.4x | 3.3x | |
Upside (Analyst Target) | - | 0.0% | 43.5% | |
Fair Value Upside | Unlock | 33.3% | 6.8% | Unlock |
Earnings
Latest Release
May 30, 2025
EPS / Forecast
-0.15 / --
Revenue / Forecast
95.92M / --
FAQ
What Stock Exchange Does Sofiva Genomics Trade On?
Sofiva Genomics is listed and trades on the Taipei Exchange stock exchange.
What Is the Stock Symbol for Sofiva Genomics?
The stock symbol for Sofiva Genomics is "6615."
What Is the Sofiva Genomics Market Cap?
As of today, Sofiva Genomics market cap is 711.50M.
What Is Sofiva Genomics's Earnings Per Share (TTM)?
The Sofiva Genomics EPS (TTM) is 0.13.
When Is the Next Sofiva Genomics Earnings Date?
Sofiva Genomics will release its next earnings report on 04 Nov 2025.
From a Technical Analysis Perspective, Is 6615 a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has Sofiva Genomics Stock Split?
Sofiva Genomics has split 0 times.
How Many Employees Does Sofiva Genomics Have?
Sofiva Genomics has 0 employees.
What is the current trading status of Sofiva Genomics (6615)?
As of 09 Aug 2025, Sofiva Genomics (6615) is trading at a price of 32.95, with a previous close of 39.90. The stock has fluctuated within a day range of 30.80 to 32.95, while its 52-week range spans from 29.00 to 58.60.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.